Mechanistic insights into how cichoriin inhibits P2Y14R to suppress MSU-induced gouty inflammation
BACKGROUND: Gout is a prevalent, chronic inflammatory joint diseases, and its global prevalence and incidence are continue to rise. Currently, the adverse side effects of anti-gout drugs underscore the urgent need for safer and more effective anti-gout agents. OBJECTIVE: Cichoriin is a kind of coumarin, which exhibits diversity of biological activities. The current investigation aimed to explore the mechanism of the inhibition of MSU-induced gouty inflammation by cichoriin. METHODS: R were obtained by molecular dynamics simulation. RESULTS: R by forming hydrogen bonds and hydrophobic interactions. CONCLUSIONS: This work highlighted the potential roles of cichoriin in attenuating MSU-induced gouty inflammation.
Authors
- Zhengqi Liu (ORCID: https://orcid.org/0000-0001-8540-2989)
- Xue Wu (ORCID: https://orcid.org/0000-0002-0511-9436)
- Li Leng (ORCID: https://orcid.org/0000-0002-4999-4742)
- Shanshan Liu
Institutions
- Guiyang College of Traditional Chinese Medicine (CN)
- Guizhou University (CN)
- Affiliated Hospital of Guizhou Medical University (CN)
Publication Details
- Journal
- BMC Biotechnology
- Published
- 2026-04-15
- DOI
- https://doi.org/10.1186/s12896-026-01151-z
- Primary Topic
- Gout, Hyperuricemia, Uric Acid
- Type
- article
- Field-Weighted Citation Impact
- 0.00